fesoterodini fumaras 8.0 mg corresp. fesoterodinum 6.2 mg, glyceroli dibehenas, hypromellosum, talcum, lactosum monohydricum 124.125 mg, cellulosum microcristallinum, Überzug: poly(alcohol vinylicus), talcum, E 171, glyceroli monocaprylocapras, natrii laurilsulfas corresp. natrium 0.045 mg, E 132, E 172 (rubrum), pro compresso obducto.
Packungsbestandteile
Delayed release tablets
Active Agent
Dose
Fesoterodini Fumaras
8 mg correspond Fesoterodinum 6.2 mg
BAG: Active Agent
Dose
Fesoterodini Fumaras
8 mg
Inactive agents
Dose
additional_information
(Rubrum)
Cellulosum Microcristallinum
E 132
color.
E 171
color.
E 172
color.
Glyceroli Dibehenas
Glyceroli Monocaprylocapras
Hypromellosum
Lactose Monohydrate
124.125 mg
Natrii Laurilsulfas
Poly(Alcohol Vinylicus)
Überzug
Pro Compresso Obducto
Talcum
Source
Data was imported : 04.10.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :